Insider · CIK 0001510349

Hasara Garrison J.

Reports to the SEC for 2 companies · TAMPA, FL

sec.gov

Transactions

Companies

Filings

CIK

0001510349

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-12-22	INTIInhibitor Therapeutics, Inc. · Common Stock OptionA Award	CFO and Treasurer	AAward	+125K sh	—	—	125,000
2020-09-17	INTIInhibitor Therapeutics, Inc. · Common Stock OptionA Award	CFO and Treasurer	AAward	+100K sh	—	—	100,000
2019-12-02	INTIInhibitor Therapeutics, Inc.P Purchase	CFO and Treasurer	PPurchase	+13.5K sh	$0.07	+$945	3,972,544
2018-08-30	INTIInhibitor Therapeutics, Inc.S Sale	CFO and Treasurer	SSale	−100K sh	$0.27	−$27K	3,959,044
2018-03-13	INTIInhibitor Therapeutics, Inc. · Common Stock OptionA Award	CFO and Treasurer	AAward	+260K sh	—	—	260,000
2017-03-08	INTIInhibitor Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	−3.5M sh	—	—	0
2017-03-08	INTIInhibitor Therapeutics, Inc.M Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	+3.5M sh	—	—	5,529,522
2017-03-08	INTIInhibitor Therapeutics, Inc.M Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	+3.5M sh	—	—	3,500,000
2017-03-08	INTIInhibitor Therapeutics, Inc.F Tax Payment	CFO and Treasurer	FTax Payment	−1.47M sh	$0.34	−$500K	2,029,522
2017-03-08	INTIInhibitor Therapeutics, Inc.F Tax Payment	CFO and Treasurer	FTax Payment	−1.47M sh	$0.34	−$500K	4,059,044
2017-03-08	INTIInhibitor Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	−3.5M sh	—	—	0
2014-08-06	INTIInhibitor Therapeutics, Inc. · Restricted Stock UnitsA Award	CFO and Treasurer	AAward	+3.5M sh	—	—	3,500,000
2014-08-06	INTIInhibitor Therapeutics, Inc. · Restricted Stock UnitsA Award	CFO and Treasurer	AAward	+3.5M sh	—	—	3,500,000
2012-08-24	ACCENTIA BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Acting Chief Financial Officer	AAward	+110K sh	—	—	109,654
2012-02-29	ACCENTIA BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Acting Chief Financial Officer	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Dec 284
Hasara Garrison J.0000899243-20-035203
SEC(opens sec.gov)
Sep 214
Hasara Garrison J.0000899243-20-025806
SEC(opens sec.gov)
Dec 24
Hasara Garrison J.0000899243-19-028374
SEC(opens sec.gov)
Aug 314
Hasara Garrison J.0000899243-18-023650
SEC(opens sec.gov)
Mar 154
Hasara Garrison J.0000899243-18-007584
SEC(opens sec.gov)
Mar 104
HedgePath Pharmaceuticals, Inc.0000899243-17-007153
SEC(opens sec.gov)
Feb 65
HedgePath Pharmaceuticals, Inc.0001209191-15-010364
SEC(opens sec.gov)
Sep 144
Hasara Garrison J.0001181431-12-050576
SEC(opens sec.gov)
Mar 24
Hasara Garrison J.0001181431-12-013879
SEC(opens sec.gov)

Companies

Address

324 SOUTH HYDE PARK AVENUE SUITE 350

TAMPA, FL, 33606